Has anyone done a bit of reading on the above mentioned adaptive platform trial?
I see they are finishing up the current trial and plan to launch a new, better one soon. The new trial will be in collaboration with the Global Coalition for Adaptive Research (GCAR).
For anyone not familiar with adaptive platform trials, they are usually phase 2/3 trials with rolling addition of new cohorts of novel therapies as they get accepted into the trial. Usually a single control group to benchmark against all the other cohorts.
Saves heaps time and money for companies developing novel therapies.
https://pancan.org/research/precision-promise/
Has anyone done a bit of reading on the above mentioned adaptive...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
0.005(2.13%) |
Mkt cap ! $116.7M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 24.5¢ | 22.5¢ | $2.020M | 8.588M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 230225 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 778184 | 1 |
View Market Depth
| Last trade - 16.10pm 30/07/2025 (20 minute delay) ? |
| ATX (ASX) Chart |